Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature

Detalles Bibliográficos
Autores principales: Karonitsch, Thomas, Yeghiazaryan, Lusine, Lackner, Angelika, Brezinsek, Hans Peter, Stamm, Tanja A, König, Franz, Aletaha, Daniel, Smolen, Josef S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594563/
https://www.ncbi.nlm.nih.gov/pubmed/36270746
http://dx.doi.org/10.1136/rmdopen-2022-002525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594563/
https://www.ncbi.nlm.nih.gov/pubmed/36270746
http://dx.doi.org/10.1136/rmdopen-2022-002525

Ejemplares similares